QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer 期刊论文 JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 卷号: 234, 期号: 3 作者:  Ma, Yun;  Bu, Deyong;  Long, Jiang;  Chai, Wenying;  Dong, Jian 收藏  |  浏览/下载：32/0  |  提交时间：2019/12/04 apoptosis  breast cancer  DSCAM-AS1  epidermal growth factor receptor pathway substrate 8 (EPS8)  mircoRNA-137 (miR-137)   A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation 期刊论文 Journal of Experimental & Clinical Cancer Research, 2019, 卷号: Vol.38 No.1 作者:  Meifang Li;  Jilong Yang;  Lenghe Zhang;  Sanfang Tu;  Xuan Zhou 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/13 Epidermal growth factor receptor (EGFR)  Epidermal growth factor receptor pathway substrate 8 (Eps8)  Breast cancer  NSCLC, small-molecule inhibitor   A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation. 期刊论文 Journal of Experimental & Clinical Cancer Research, 2019, 卷号: Vol.38 No.1 作者:  Li, Meifang;  Yang, Jilong;  Zhang, Lenghe;  Tu, Sanfang;  Zhou, Xuan 收藏  |  浏览/下载：17/0  |  提交时间：2019/12/13 Breast cancer  Epidermal growth factor receptor (EGFR)  Epidermal growth factor receptor pathway substrate 8 (Eps8)  NSCLC, small-molecule inhibitor   A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation 期刊论文 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: Vol.38 作者:  Li, MF;  Yang, JL;  Zhang, LH;  Tu, SF;  Zhou, X 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/17 Epidermal growth factor receptor (EGFR)  Epidermal growth factor receptor pathway substrate 8 (Eps8)  Breast cancer  NSCLC  small-molecule inhibitor